✦ LIBER ✦

Direct costs of managing Parkinson's disease in india: Concerns in a developing country

✍ Scribed by Mona Ragothaman; Shyla T. Govindappa; Rohini Rattihalli; Dodaballapur K. Subbakrishna; Uday B. Muthane

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 61 KB
Volume: 21
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.21035

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Medicines and surgical interventions improve the quality of life of Parkinson's disease (PD) patients. These are still expensive options and are unaffordable to those living in developing countries. Managing PD in Indians who have a low annual gross national income (GNI; US$ 450–540) and for whom only a few (3%) have health insurance is a challenge. We interviewed 175 consecutive PD patients regarding health insurance and money spent for treatment. The annual income of nearly half the patients was less than rupees 50,000 (US$ 1,148.63). Patients in this study spend nearly 16% to 41.7% of the average Indian GNI to buy medicines. Costs of treating PD in India are lower than those in developed nations but are still out of reach for most Indian patients. © 2006 Movement Disorder Society

📜 SIMILAR VOLUMES

Cost of Alzheimer's disease in a develop

Cost of Alzheimer's disease in a developing country setting

✍ M. Zencir; N. Kuzu; N. Gördeles Beşer; A. Ergin; B. Çatak; T. Şahiner 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

Purpose To evaluate the economic impact of AD in Denizli, Turkey. Design and Methods This observational study was conducted with 42 AD patients and their primary caregivers. During the initial interview, demographic data and medical histories were collected with questionnaires. For an observational

Economic burden of Parkinson's disease i

Economic burden of Parkinson's disease in a developing country: A retrospective cost analysis in Shanghai, China

✍ Gang Wang; Qi Cheng; Rui Zheng; Yu-Yan Tan; Xiao-Kang Sun; Hai-Yan Zhou; Xiao-La 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

## Abstract We investigated economic costs from patients with Parkinson's disease (PD) in Shanghai, China, which could be used as a baseline for future evaluations. Data were collected from 190 patients by interview during 1‐year period. Direct medical care costs averaged approximately Chinese yuan

Resource use and costs in a Swedish coho

Resource use and costs in a Swedish cohort of patients with Parkinson's disease

✍ Peter Hagell; Sara Nordling; Jan Reimer; Martin Grabowski; Ulf Persson 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

We estimated resource use and costs in patients with Parkinson's disease (PD), thereby providing baseline data for future economic evaluations of therapeutic interventions. Data were collected from medical records of a South Swedish cohort of 127 PD patients during 1 year (1996) and a mailed questio

Validity of a modified Parkinson's disea

Validity of a modified Parkinson's disease screening questionnaire in India: Effects of literacy of participants and medical training of screeners and implications for screening efforts in developing countries

✍ Nagaraja Sarangmath; Rohini Rattihalli; Mona Ragothaman; Gururaj Gopalkrishna; S 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB 👁 1 views

## Abstract The prevalence of Parkinson's disease (PD) is low among Indians, except in the Parsis. Data for Indians come from studies using different screening tools and criteria to detect PD. An epidemiological study in India, which has nearly a billion people, more than 18 spoken languages, and v

Stem cells in development of therapeutic

Stem cells in development of therapeutics for Parkinson's disease: A perspective

✍ Jiajie Xi; Su-Chun Zhang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

## Abstract Using Parkinson's disease as a prototype of neurodegenerative diseases, we propose applications of human stem cells in the development of therapeutics for neurodegenerative diseases. First, in vitro differentiation of human stem cells offers a versatile model for dissecting molecular in

Direct economic impact of Parkinson's di

Direct economic impact of Parkinson's disease: A research survey in the United Kingdom

✍ Leslie Findley; Manjit Aujla; Peter G. Bain; Mary Baker; Catherine Beech; Clive 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 1 views

## Abstract The direct costs of care were evaluated prospectively in a sample of people with Parkinson's disease (PD) in the United Kingdom in 1998. The subjects were drawn from a random sample of general practitioner practices within a representative sample of 36 Regional Health Authorities and th